New York State Common Retirement Fund Rigel Pharmaceuticals Inc Transaction History

New York State Common Retirement Fund

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	SELL	$1.12 - $1.57 $273 - $383	-244 Reduced 0.73%	33,198 $49,000
Q4 2023 Feb 01, 2024	SELL	$0.72 - $1.56 $205 - $444	-285 Reduced 0.85%	33,442 $48,000
Q3 2023 Nov 07, 2023	BUY	$1.07 - $1.39 $571 - $742	534 Added 1.61%	33,727 $36,000
Q2 2023 Aug 07, 2023	SELL	$1.12 - $1.82 $277 - $451	-248 Reduced 0.74%	33,193 $43,000
Q1 2023 May 02, 2023	SELL	$1.25 - $2.0 $85,125 - $136,200	-68,100 Reduced 67.07%	33,441 $44,000
Q4 2022 Jan 30, 2023	BUY	$0.67 - $11.9 $51 - $916	77 Added 0.08%	101,541 $152,000
Q3 2022 Nov 08, 2022	BUY	$1.1 - $12.2 $295 - $3,281	269 Added 0.27%	101,464 $120,000
Q2 2022 Aug 04, 2022	SELL	$0.67 - $3.19 $225 - $1,071	-336 Reduced 0.33%	101,195 $114,000
Q1 2022 May 05, 2022	BUY	$2.22 - $3.45 $182 - $282	82 Added 0.08%	101,531 $304,000
Q4 2021 Feb 02, 2022	SELL	$2.36 - $3.57 $797 - $1,206	-338 Reduced 0.33%	101,449 $269,000
Q3 2021 Nov 02, 2021	SELL	$3.5 - $4.5 $90,135 - $115,888	-25,753 Reduced 20.19%	101,787 $369,000
Q2 2021 Aug 02, 2021	SELL	$3.09 - $4.54 $67,547 - $99,244	-21,860 Reduced 14.63%	127,540 $554,000
Q4 2018 Feb 08, 2019	SELL	$2.08 - $3.36 $3,120 - $5,040	-1,500 Reduced 0.99%	149,400 $344,000
Q2 2018 Aug 10, 2018	BUY	$2.83 - $4.11 $11,037 - $16,029	3,900 Added 2.65%	150,900 $427,000
Q1 2018 May 10, 2018	BUY	$3.54 - $4.54 $111,864 - $143,464	31,600 Added 27.38%	147,000 $520,000
Q2 2017 Aug 11, 2017	BUY	N/A	115,400	115,400 $315,000

335K

Ticker RIGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 172,836,000
Market Cap $3.72B
Description
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on New York State Common Retirement Fund with notifications on news.